The Application of Cell Surface Markers to Demarcate Distinct Human Pluripotent States

Overview

Journal Exp Cell Res

Specialty Cell Biology

Date 2019 Dec 3

PMID 31790696

Citations 3

Authors

Jacob Goodwin

Andrew L Laslett

Peter J Rugg-Gunn

Affiliations

Soon will be listed here.

Abstract

Recent advances in human pluripotent stem cell (hPSC) research have uncovered different subpopulations within stem cell cultures and have captured a range of pluripotent states that hold distinct molecular and functional properties. At the two ends of the pluripotency spectrum are naïve and primed hPSC, whereby naïve hPSC grown in stringent conditions recapitulate features of the preimplantation human embryo, and the conventionally grown primed hPSC align closer to the early postimplantation embryo. Investigating these cell types will help to define the mechanisms that control early development and should provide new insights into stem cell properties such as cell identity, differentiation and reprogramming. Monitoring cell surface marker expression provides a valuable approach to resolve complex cell populations, to directly compare between cell types, and to isolate viable cells for functional experiments. This review discusses the discovery and applications of cell surface markers to study human pluripotent cell types with a particular focus on the transitions between naïve and primed states. Highlighted areas for future study include the potential functions for the identified cell surface proteins in pluripotency, the production of new high-quality monoclonal antibodies to naïve-specific protein epitopes and the use of cell surface markers to characterise subpopulations within pluripotent states.

Citing Articles

sBioSITe enables sensitive identification of the cell surface proteome through direct enrichment of biotinylated peptides.

Garapati K, Ding H, Charlesworth M, Kim Y, Zenka R, Saraswat M Clin Proteomics. 2023; 20(1):56.

PMID: 38053024 PMC: 10696767. DOI: 10.1186/s12014-023-09445-6.

Robust genome and RNA editing via CRISPR nucleases in PiggyBac systems.

Jiang Y, Hoenisch R, Chang Y, Bao X, Cameron C, Lian X Bioact Mater. 2022; 14:313-320.

PMID: 35386818 PMC: 8964983. DOI: 10.1016/j.bioactmat.2022.01.046.

Cell-Surface Proteomics Identifies Differences in Signaling and Adhesion Protein Expression between Naive and Primed Human Pluripotent Stem Cells.

Wojdyla K, Collier A, Fabian C, Nisi P, Biggins L, Oxley D Stem Cell Reports. 2020; 14(5):972-988.

PMID: 32302559 PMC: 7220956. DOI: 10.1016/j.stemcr.2020.03.017.

References

Drukker M, Tang C, Ardehali R, Rinkevich Y, Seita J, Lee A . Isolation of primitive endoderm, mesoderm, vascular endothelial and trophoblast progenitors from human pluripotent stem cells. Nat Biotechnol. 2012; 30(6):531-42. PMC: 3672406. DOI: 10.1038/nbt.2239. View

Rohrs S, Scherr M, Romani J, Zaborski M, Drexler H, Quentmeier H . CD7 in acute myeloid leukemia: correlation with loss of wild-type CEBPA, consequence of epigenetic regulation. J Hematol Oncol. 2010; 3:15. PMC: 2873354. DOI: 10.1186/1756-8722-3-15. View

Rugg-Gunn P, Cox B, Lanner F, Sharma P, Ignatchenko V, McDonald A . Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells. Dev Cell. 2012; 22(4):887-901. PMC: 3405530. DOI: 10.1016/j.devcel.2012.01.005. View

Rossant J, Tam P . New Insights into Early Human Development: Lessons for Stem Cell Derivation and Differentiation. Cell Stem Cell. 2017; 20(1):18-28. DOI: 10.1016/j.stem.2016.12.004. View

OBrien C, Chy H, Zhou Q, Blumenfeld S, Lambshead J, Liu X . New Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem Cells. Stem Cells. 2016; 35(3):626-640. PMC: 5412944. DOI: 10.1002/stem.2558. View

Cornacchia D, Zhang C, Zimmer B, Chung S, Fan Y, Soliman M . Lipid Deprivation Induces a Stable, Naive-to-Primed Intermediate State of Pluripotency in Human PSCs. Cell Stem Cell. 2019; 25(1):120-136.e10. PMC: 7549840. DOI: 10.1016/j.stem.2019.05.001. View

Stirparo G, Boroviak T, Guo G, Nichols J, Smith A, Bertone P . Integrated analysis of single-cell embryo data yields a unified transcriptome signature for the human pre-implantation epiblast. Development. 2018; 145(3). PMC: 5818005. DOI: 10.1242/dev.158501. View

Collier A, Rugg-Gunn P . Identifying Human Naïve Pluripotent Stem Cells - Evaluating State-Specific Reporter Lines and Cell-Surface Markers. Bioessays. 2018; 40(5):e1700239. DOI: 10.1002/bies.201700239. View

Yan L, Yang M, Guo H, Yang L, Wu J, Li R . Single-cell RNA-Seq profiling of human preimplantation embryos and embryonic stem cells. Nat Struct Mol Biol. 2013; 20(9):1131-9. DOI: 10.1038/nsmb.2660. View

10.

Liu X, Nefzger C, Rossello F, Chen J, Knaupp A, Firas J . Comprehensive characterization of distinct states of human naive pluripotency generated by reprogramming. Nat Methods. 2017; 14(11):1055-1062. DOI: 10.1038/nmeth.4436. View

11.

Guo G, von Meyenn F, Rostovskaya M, Clarke J, Dietmann S, Baker D . Epigenetic resetting of human pluripotency. Development. 2017; 144(15):2748-2763. PMC: 5560041. DOI: 10.1242/dev.146811. View

12.

Gafni O, Weinberger L, AlFatah Mansour A, Manor Y, Chomsky E, Ben-Yosef D . Derivation of novel human ground state naive pluripotent stem cells. Nature. 2013; 504(7479):282-6. DOI: 10.1038/nature12745. View

13.

Rostovskaya M, Stirparo G, Smith A . Capacitation of human naïve pluripotent stem cells for multi-lineage differentiation. Development. 2019; 146(7). PMC: 6467473. DOI: 10.1242/dev.172916. View

14.

Theunissen T, Powell B, Wang H, Mitalipova M, Faddah D, Reddy J . Systematic Identification of Culture Conditions for Induction and Maintenance of Naive Human Pluripotency. Cell Stem Cell. 2017; 15(4):524-526. PMC: 4534765. DOI: 10.1016/j.stem.2014.09.003. View

15.

Brons I, Smithers L, Trotter M, Rugg-Gunn P, Sun B, Chuva de Sousa Lopes S . Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature. 2007; 448(7150):191-5. DOI: 10.1038/nature05950. View

16.

Shevinsky L, Knowles B, Damjanov I, Solter D . Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell. 1982; 30(3):697-705. DOI: 10.1016/0092-8674(82)90274-4. View

17.

Fenderson B, Andrews P, Nudelman E, Clausen H, Hakomori S . Glycolipid core structure switching from globo- to lacto- and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells. Dev Biol. 1987; 122(1):21-34. DOI: 10.1016/0012-1606(87)90328-9. View

18.

Zhang T, de Waard A, Wuhrer M, Spaapen R . The Role of Glycosphingolipids in Immune Cell Functions. Front Immunol. 2019; 10:90. PMC: 6361815. DOI: 10.3389/fimmu.2019.00090. View

19.

Davidson K, Mason E, Pera M . The pluripotent state in mouse and human. Development. 2015; 142(18):3090-9. DOI: 10.1242/dev.116061. View

20.

Shakiba N, White C, Lipsitz Y, Yachie-Kinoshita A, Tonge P, Hussein S . CD24 tracks divergent pluripotent states in mouse and human cells. Nat Commun. 2015; 6:7329. PMC: 4490408. DOI: 10.1038/ncomms8329. View